Page last updated: 2024-12-08
propisochlor
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 167454 |
SCHEMBL ID | 65705 |
MeSH ID | M0445379 |
Synonyms (24)
Synonym |
---|
propisochlor |
86763-47-5 |
2-chloro-n-(2-ethyl-6-methylphenyl)-n-(propan-2-yloxymethyl)acetamide |
unii-88248r3yqc |
propisochlor [iso] |
88248r3yqc , |
acetamide, 2-chloro-n-(2-ethyl-6-methylphenyl)-n-((1-methylethoxy)methyl)- |
2-chloro-n-(2-ethyl-6-methylphenyl)-n-((1-methylethoxy)methyl)acetamide |
AKOS016014344 |
proponit |
FT-0630945 |
2-chloro-2'-ethyl-6'-methyl-n-(isopropoxymethyl)acetanilide |
SCHEMBL65705 |
propizochlor |
2-chloro-6'-ethyl-n-isopropoxymethylacet-o-toluidide |
DTXSID2058205 |
2-chloro-n-(2-ethyl-6-methylphenyl)-n-(isopropoxymethyl)acetamide |
propisochlor, pestanal(r), analytical standard |
propisochlor 10 microg/ml in cyclohexane |
Q22808795 |
1ST22401 |
AS-81806 |
acetamide, 2-chloro-n-(2-ethyl-6-methylphenyl)-n-[(1-methylethoxy)methyl]- |
CS-W020974 |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (16)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (50.00) | 29.6817 |
2010's | 7 (43.75) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 32.40
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (32.40) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 16 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |